Goodwin advised Myrobalan Therapeutics on the matter. Myrobalan Therapeutics has been granted $400,000 from the ALS Association to support the advancement of its colony-stimulating factor-1 receptor…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
